About Us

The Glycocalyx Research Institute, founded in 2012 and led by Dr. Hans Vink and Robert Long, aims to provide education and training on the endothelium glycocalyx and the microvascular system, as well as consult and design glycocalyx and microvascular-based research studies.

The Institute creates and delivers medical devices and nutritional supplements that monitor and support the health and well-being of the endothelial glycocalyx and the microvascular system.

The company’s flagship product is GlycoCheck™, a clinically validated, class-one medical device that enables monitoring and evaluation of the overall strength and dimension of the glycocalyx.

With the revolutionary patented imaging software and hardware system developed by Dr. Hans Vink, healthcare professionals can identify and monitor the contribution of microvascular dysfunction and glycocalyx damage during disease development.

The Glycocalyx Research Institute has also developed a game-changing, proprietary, anti-aging supplement, ReVasca™, which delivers the anti-aging building blocks essential to maintaining a healthy endothelial glycocalyx and capillaries in the microvascular system.

This unique combination of GlycoCheck™ and the ReVasca™ nutraceutical has proven to be successful in restoring, regenerating, and protecting the glycocalyx gel lining of the microvascular system in order to prevent organ starvation.